Assessment of the Effectiveness of Menopur in Intrauterine Insemination
NCT ID: NCT01354834
Last Updated: 2025-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
207 participants
OBSERVATIONAL
2004-03-31
2006-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
NCT01331733
A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility
NCT02835469
MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer
NCT00884221
Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility Treatment
NCT04814940
Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)
NCT04163458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hMG
hMG
Patients with a condition
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hMG
Patients with a condition
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Seminal sample suitable for artificial insemination treatment according to the criterion of each centre
* Patient prescribed therapy with Menopur in artificial insemination
Exclusion Criteria
* Contraindications to Menopur
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ferring SAU
INDUSTRY
Ferring Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ferring Pharmaceuticals
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Development Support
Role: STUDY_DIRECTOR
Ferring Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Investigational site
Elche, Alicante, Spain
Investigational site
Las Palmas, Grand Canaria, Spain
Investigational site
Santiago, La Coruña, Spain
Investigational site
Reus, Tarragona, Spain
Investigational site
Albacete, , Spain
Investigational site
Alicante, , Spain
Investigational site
Almería, , Spain
Investigational site
Barcelona, , Spain
Investigational site
Burgos, , Spain
Investigational site
León, , Spain
Investigational site
Madrid, , Spain
Investigational site
Seville, , Spain
Investigational site
Toldeo, , Spain
Investigational site
Valladolid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FER-MEN-2003-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.